Immunogenicity and protective efficacy evaluation of an inactivated Lawsonia intracellularis vaccine candidate developed on the basis of a Chinese isolate in pigs

Abstract

Porcine proliferative enteropathy (PPE), caused by the obligate intracellular bacterium Lawsonia intracellularis (LI), is an important enteric disease of pigs that impairs intestinal function and growth performance. Vaccination is the most effective measure for the prevention and control of PPE. However, it is extremely difficult to isolate and cultivate LI strains in vitro, and Enterisol®Ileitis is the only commercially available LI vaccine in China. Thus, the isolation of local LI strains and the development of LI vaccines represent urgent priorities for the Chinese swine industry. In this study, the immunogenicity and protective efficacy of an inactivated vaccine developed from the previously isolated Chinese strain LI-HuB23 were evaluated. Thirty-five LI-negative weaned pigs were initially assigned to one of three vaccination groups: those receiving the LI-HuB23-inactivated vaccine, those receiving Enterisol®Ileitis, or those receiving sucrose-phosphate-glutamate buffer (SPG). Vaccinated pigs were then challenged with either LI-HuB23 pure culture or JX703 tissue homogenate. Protection efficacy was assessed on the basis of serum LI-specific antibody responses, serum cytokine levels, average daily gain, feed conversion ratio, fecal LI shedding, fecal scores, gross ileal lesions and histopathology. The results showed that the LI-HuB23-inactivated vaccine induced rapid and sustained serum LI-specific antibody responses, with 100% seropositivity by 21 days post-immunization. Serum LI-specific antibody titers were significantly higher in the inactivated vaccine groups than in the Enterisol®Ileitis groups at 21 and 35 days post-immunization. Vaccination also increased serum IFN-γ, TNF-α and IL-6 levels. Vaccination with the LI-HuB23-inactivated vaccine significantly improved growth performance, reduced fecal scores and fecal LI shedding, and attenuated gross and histopathological ileal lesions. Overall, the LI-HuB23-inactivated vaccine induced serum LI-specific antibody and cytokine responses and reduced the adverse effects of LI challenge on growth performance, fecal shedding and ileal pathology. These findings support the further development of injectable inactivated LI vaccines.

Keywords

Porcine proliferative enteropathy / Lawsonia intracellularis / Inactivated vaccine / Immunogenicity / Protective efficacy

References

[1] Arnold M, Crienen A, Swam H, von Berg S, Jolie R, Nathues H. Prevalence of Lawsonia intracellularis in pig herds in different European countries. Porcine Health Management, 2019, 5 31

[2] Campillo M, Smith SH, Gally DL, Opriessnig T. Review of methods for the detection of Lawsonia intracellularis infection in pigs. Journal of Veterinary Diagnostic Investigation, 2021, 33(4621-631

[3] Casanova JL, MacMicking JD, Nathan CF. Interferon-γ and infectious diseases: Lessons and prospects. Science, 2024, 384(6693 eadl2016

[4] Chagas S, Jensen P, Paladino E, Pascoal LM, von Berg S, Gebhart C, Vannucci FA. Immune response of pigs vaccinated against proliferative enteropathy and coinfected with Lawsonia intracellularis and Brachyspira hyodysenteriae. Animals, 2025, 16(1 114

[5] Collins AM, Barchia IM. The critical threshold of Lawsonia intracellularis in pig feces that causes reduced average daily weight gains in experimentally challenged pigs. Veterinary Microbiology, 2014, 168(2–4): 455-458

[6] Cordes H, Riber U, Jensen TK, Ståhl M, Jungersen G. Cell-mediated and humoral immune responses in pigs following primary and challenge-exposure to Lawsonia intracellularis. Veterinary Research, 2012, 43: 9

[7] Corzo CA, Friendship R, Dewey C, Blackwell T. Comparison of 2 serologic tests for the diagnosis of porcine proliferative enteropathy. Canadian Veterinary Journal, 2005, 46(5): 433-435

[8] De Oliveira Possa, L., V. D. S. Romagnoli, R. L. Senra, and T. A. de Oliveira Mendes. 2026. Efficiency of commercial and test vaccines against Lawsonia intracellularis on clinical and immunological parameters in swine: A systematic review. Brazilian Journal of Microbiology 57 (1). https://doi.org/10.1007/s42770-026-01873-4.

[9] Djur, F., 2021. Enterisol® Ileitis vet. (frystorkat pulver och vätska till oral suspension): Produktresumé. https://fass.se/animal/product/20041222000014/smpc. Accessed 9 August 2026.

[10] Elahi S, Thompson DR, van Kessel J, Babiuk LA, Gerdts V. Protective role of passively transferred maternal cytokines against Bordetella pertussis infection in newborn piglets. Infection and Immunity, 2017, 85(4 e01063-16

[11] Fourie KR, Jeffery A, Chand D, Choudhary P, Ng SH, Liu H, Magloire D, Khatooni Z, Berberov E, Wilson HL. Vaccination with a Lawsonia intracellularis subunit water-in-oil emulsion vaccine mitigated some disease parameters but failed to affect shedding. Vaccine, 2024, 42(24 126254

[12] Guedes RM, Gebhart CJ. Comparison of intestinal mucosa homogenate and pure culture of the homologous Lawsonia intracellularis isolate in reproducing proliferative enteropathy in swine. Veterinary Microbiology, 2003, 93(2): 159-166

[13] Guedes RM, Gebhart CJ. Onset and duration of fecal shedding, cell-mediated and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated vaccine strain of Lawsonia intracellularis. Veterinary Microbiology, 2003, 91(2–3): 135-145

[14] Guedes RM, Gebhart CJ, Deen J, Winkelman NL. Validation of an immunoperoxidase monolayer assay as a serologic test for porcine proliferative enteropathy. Journal of Veterinary Diagnostic Investigation, 2002, 14(6): 528-530

[15] Guedes RM, Gebhart CJ, Winkelman NL, Mackie-Nuss RA. A comparative study of an indirect fluorescent antibody test and an immunoperoxidase monolayer assay for the diagnosis of porcine proliferative enteropathy. Journal of Veterinary Diagnostic Investigation, 2002, 14(5): 420-423

[16] Helm ET, Burrough ER, Gabler NK, Leite FL. Lawsonia intracellularis infection induces changes in microbial community function and composition associated with reduced pig growth and feed efficiency. Animal Microbiome, 2026, 8 1

[17] Helm ET, Burrough ER, Leite FL, Gabler NK. Lawsonia intracellularis-infected enterocytes lack sucrase-isomaltase which contributes to reduced pig digestive capacity. Veterinary Research, 2021, 52 90

[18] Jacobs AAC, Harks F, Hazenberg L, Hoeijmakers MJH, Nell T, Pel S, Segers R. Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions. Vaccine, 2019, 37(15): 2149-2157

[19] Jacobs AAC, Harks F, Pauwels R, Cao Q, Holtslag H, Pel S, Segers R. Efficacy of a novel intradermal Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions. Porcine Health Management, 2020, 6 25

[20] Jacobson M, Hård af Segerstad C, Gunnarsson A, Fellström C, de Verdier Klingenberg K, Wallgren P, Jensen-Waern M. Diarrhea in the growing pig: A comparison of clinical, morphological and microbial findings between animals from good and poor performance herds. Research in Veterinary Science, 2003, 74(2): 163-169

[21] Joens LA, Nibbelink S, Glock RD. Induction of gross and microscopic lesions of porcine proliferative enteritis by Lawsonia intracellularis. American Journal of Veterinary Research, 1997, 58(10): 1125-1131

[22] Johansen M, Nielsen M, Dahl J, Svensmark B, Bækbo P, Kristensen CS, Hjulsager CK, Jensen TK, Ståhl M, Larsen LE, et al.. Investigation of the association of growth rate in grower-finishing pigs with the quantification of Lawsonia intracellularis and porcine circovirus type 2. Preventive Veterinary Medicine, 2013, 108(1): 63-72

[23] Khatooni Z, Broderick G, Anand SK, Wilson HL. Combined immunoinformatic approaches with computational biochemistry for development of subunit-based vaccine against Lawsonia intracellularis. PLoS ONE, 2025, 20(2 e0314254

[24] Kiesslich S, Kamen AA. Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnology Advances, 2020, 44 107608

[25] Lawson GH, Gebhart CJ. Proliferative enteropathy. Journal of Comparative Pathology, 2000, 122(2–3): 77-100

[26] Lawson GH, McOrist S, Jasni S, Mackie RA. Intracellular bacteria of porcine proliferative enteropathy: Cultivation and maintenance in vitro. Journal of Clinical Microbiology, 1993, 31(5): 1136-1142

[27] Leite FL, Galvis JA, Beckler D, McOrist S. Evaluation of the transmission dynamics of Lawsonia intracellularis in swine. Preventive Veterinary Medicine, 2026, 252 106872

[28] Li X, Körner H, Liu X. Susceptibility to intracellular infections: Contributions of TNF to immune defense. Frontiers in Microbiology, 2020, 11 1643

[29] Magtoto RL, Vegi A, Wang C, Johnson JK, Ramamoorthy S. Evaluation and use of a serological assay for the detection of antibodies to Lawsonia intracellularis in swine. International Journal of Veterinary Science and Medicine, 2014, 2(2): 109-113

[30] McOrist S, Gebhart CJ, Boid R, Barns SM. Characterization of Lawsonia intracellularis gen. nov., sp. nov., the obligately intracellular bacterium of porcine proliferative enteropathy. International Journal of Systematic Bacteriology, 1995, 45(4): 820-825

[31] McOrist S, Mackie RA, Lawson GH, Smith DG. In vitro interactions of Lawsonia intracellularis with cultured enterocytes. Veterinary Microbiology, 1997, 54(3–4): 385-392

[32] Musse SL, Nielsen GB, Stege H, Weber NR, Houe H. Effect of intramuscular vaccination against Lawsonia intracellularis on production parameters, diarrhea occurrence, antimicrobial treatment, bacterial shedding, and lean meat percentage in two Danish naturally infected finisher pig herds. Preventive Veterinary Medicine, 2023, 212 105837

[33] Nogueira MG, Collins AM, Dunlop RH, Emery D. Effect of the route of administration on the mucosal and systemic immune responses to Lawsonia intracellularis vaccine in pigs. Australian Veterinary Journal, 2015, 93(4): 124-126

[34] Obradovic M, Pasternak JA, Ng S. Hon, Allan B, Brownlie R, Wilson HL. Immunoproteomic analysis of Lawsonia intracellularis identifies candidate neutralizing antibody targets for use in subunit vaccine development. Veterinary Microbiology, 2019, 235: 270-279

[35] Paradis M-A, Gebhart C, Toole D, Vessie G, Winkelman N, Bauer S, Wilson J, McClure C. Subclinical ileitis: Diagnostic and performance parameters in a multidose mucosal homogenate challenge model. Journal of Swine Health and Production, 2012, 20(3): 137-141

[36] Park S, Lee JB, Kim KJ, Oh YS, Kim MO, Oh YR, Hwang MA, Lee JA, Lee SW. Efficacy of a commercial live attenuated Lawsonia intracellularis vaccine in a large-scale field trial in Korea. Clinical and Experimental Vaccine Research, 2013, 2(2): 135-139

[37] Pedersen KS, Skrubel R, Stege H, Angen Ø, Ståhl M, Hjulsager C, Larsen LE, Nielsen JP. Association between average daily gain, fecal dry matter content and concentration of Lawsonia intracellularis in feces. Acta Veterinaria Scandinavica, 2012, 54: 58

[38] Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, Emerson M, et al.. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biology, 2020, 18(7 e3000411

[39] Riber U, Heegaard PM, Cordes H, Ståhl M, Jensen TK, Jungersen G. Vaccination of pigs with attenuated Lawsonia intracellularis induced acute phase protein responses and primed cell-mediated immunity without reduction in bacterial shedding after challenge. Vaccine, 2015, 33(1): 156-162

[40] Roerink F, Morgan CL, Knetter SM, Passat MH, Archibald AL, Ait-Ali T, Strait EL. A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function. Vaccine, 2018, 36(11): 1500-1508

[41] Rose-John S, Winthrop K, Calabrese L. The role of IL-6 in host defense against infections: Immunobiology and clinical implications. Nature Reviews Rheumatology, 2017, 13(7): 399-409

[42] Schijns VE, Lavelle EC. Trends in vaccine adjuvants. Expert Review of Vaccines, 2011, 10(4): 539-550

[43] Seo HW, Han K, Oh Y, Park C, Choo EJ, Kim SH, Lee BH, Chae C. Comparison of cell-mediated immunity induced by three commercial single-dose Mycoplasma hyopneumoniae bacterins in pigs. Journal of Veterinary Medical Science, 2013, 75(2): 245-247

[44] Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology, 2014, 6(10 a016295

[45] Thakur A, Mikkelsen H, Jungersen G. Intracellular pathogens: Host immunity and microbial persistence strategies. Journal of Immunology Research, 2019

[46] Vannucci FA, Gebhart CJ. Recent advances in understanding the pathogenesis of Lawsonia intracellularis infections. Veterinary Pathology, 2014, 51(2): 465-477

[47] Vannucci FA, Beckler D, Pusterla N, Mapes SM, Gebhart CJ. Attenuation of virulence of Lawsonia intracellularis after in vitro passages and its effects on the experimental reproduction of porcine proliferative enteropathy. Veterinary Microbiology, 2013, 162(1): 265-269

[48] Vannucci FA, Gebhart CJ, McOrist SZimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J. Proliferative enteropathy. Diseases of swine, 2019, 11th ed., Hoboken Wiley-Blackwell, 898-911

[49] Vannucci FA, Wattanaphansak S, Gebhart CJ. An alternative method for cultivation of Lawsonia intracellularis. Journal of Clinical Microbiology, 2012, 50(3): 1070-1072

[50] Wattanaphansak S, Gebhart CJ, Anderson JM, Singer RS. Development of a polymerase chain reaction assay for quantification of Lawsonia intracellularis. Journal of Veterinary Diagnostic Investigation, 2010, 22(4): 598-602

[51] Won G, Chi NK, Park Y. The effectiveness of commercial vaccination against Lawsonia intracellularis in mitigating the reduction in ADWG, the increased mortality and fecal shedding of the vaccinated pigs: A systematic review and meta-analysis. Veterinary Sciences, 2022, 9(10 536

[52] Wu W, Wang L, Xie R, Peng C, Yang H, Zhu H, Luo Y, Hua L, Chen H, Wu B, et al.. Development and application of a triplex real-time PCR method for the detection of Lawsonia intracellularis, Brachyspira hyodysenteriae, and Clostridium perfringens. Microbiology Spectrum, 2025, 13(6 e03237-24

[53] Xie R, Gu Z-Q, Liu S-W, Luo Y-J, Cui Y-C, Hua L, Song W-B, Huang C, Tang X-B, Xu G-Y, et al.. Establishment of an infection model in pigs for Chinese clinical strains of Lawsonia intracellularis. Scientia Agricultura Sinica, 2026, 59(15): 3452-3464

[54] Xie R, Luo Y, Peng C, Wu W, Cui Y, Sun X, Hua L, Wu B, Peng Z. Isolation, passage, and pathogenicity of a newly isolated Lawsonia intracellularis strain from Hubei, China. Transboundary and Emerging Diseases, 2025

[55] Yang J, Guertin P, Jia G, Lv Z, Yang H, Ju D. Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors. AMB Express, 2019, 9 70

Funding

Hubei Provincial Science and Technology Project(2025BBA004)

Open Project of Hubei Jiangxia Laboratory(2025JXQJKKF008)

Hubei Hongshan Laboratory & Huazhong Agricultural University Startup Fund

Rights & permissions

The Author(s)